A group of researchers led by Ramon Sun, a biochemist and molecular biologist at the University of Florida, reported this week that they identified a potential new driver of Alzheimer’s disease progression: Glucosamine. The discovery emerged from a new technique called multi-imaging, developed by Sun’s laboratory, which allows scientists to examine the brain in unprecedented molecular detail.